FDA sends small biotech and its reformulated pain med packing, triggering a collapse in the share price
A small-cap biotech founded by Fortress has run into a brick wall at the FDA.
Avenue Therapeutics $ATXI says the agency has hit it with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
